Experimental characterisation of the withdrawal syndrome after 14 days treatment with clonazepam.
Toreva
D
D
Kostadinova
I
I
D000818:Animals; D002998:Clonazepam / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D008297:Male; D009043:Motor Activity / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000209:etiology; D012727:Sex Characteristics; D013375:Substance Withdrawal Syndrome / Q000150:complications / Q000503:physiopathology*
D002998:Clonazepam